September 6, 2026
Currax Expands Patient Access to FDA-Approved Obesity Treatment with PeekDirect™
B Contrave, the #1 branded oral non-GLP-1 weight loss medication* is now available to self-funded employers through Peek BRENTWOOD, Tenn., April 1, 2026 /PRNewswire/ — Currax…
